Intervention Summary
Moderate-to-vigorous exercise (~90 min/week) as adjunctive therapy alongside antipsychotics. The strongest evidence base of any non-pharmacological intervention for schizophrenia, with meta-analytic support for both psychiatric symptom reduction and metabolic benefit.
Evidence
Meta-Analysis (Firth 2015)
- Design: Systematic review and meta-analysis of 17 trials (11 RCTs), n=659
- Psychiatric outcomes: Symptoms significantly reduced (SMD 0.72, 95% CI -1.14 to -0.29)
- Physical outcomes: Improved fitness and cardiometabolic risk factors; no significant effect on BMI alone
- Cognitive outcomes: Improved neurocognition and functioning
- Yoga-specific: Greater effects on facial emotion recognition than standard exercise
- Source: firth 2015 exercise schizophrenia systematic review meta analysis
Mechanism
Exercise targets the schizophrenia signature through multiple convergent pathways:
- Neuroinflammation reduction: Exercise reduces microglial M1 polarization markers and promotes M2 transition
- BDNF enhancement: Exercise increases brain-derived neurotrophic factor, counteracting the neuroplasticity deficits in schizophrenia
- Metabolic syndrome counteraction: The 5x metabolic syndrome incidence and 15 kg weight gain associated with antipsychotics make exercise essential for survival — metabolic comorbidities drive the 15-20 year life expectancy reduction
- Microbiome diversity: Exercise is known to increase gut microbial alpha-diversity and butyrate-producing taxa, though this was not directly measured in schizophrenia exercise trials
Clinical Context
Exercise is the only schizophrenia intervention that simultaneously addresses psychiatric symptoms, metabolic risk, cardiovascular risk, cognitive deficits, and potentially the gut microbiome. The 90 min/week threshold is achievable even for patients with negative symptoms (anhedonia, avolition) when structured as supervised group programs. The negligible risk profile makes this a universal recommendation for schizophrenia patients.